Evidence lead: Ranks twenty-six through thirty · Lower-middle appeal uptake
UPMC Health Plan MA: Appeal filing trailed the table midpoint
Filed appeals account for 15.0% of this contract's denials, or 1,427 records. That is rank #27 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.
Ranks twenty-six through thirty · Lower-middle appeal uptake
Appeal filing trailed the table midpoint
Filed appeals account for 15.0% of this contract's denials, or 1,427 records. That is rank #27 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.
Ranks eleven through fifteen · Upper-middle overturn cohort
Appeal overturns ran above most contracts
The observed overturn rate is 73.0%, in the upper-middle portion of the table. Its overturn-rate rank is #14 of 37. The denominator is filed appeals, not all authorization requests. The percentage therefore describes reviewed appeals and must not be read as an individual outcome forecast.
Ranks eleven through fifteen · Upper-middle reversal reach
Reversals covered an above-median share of denials
Overturned appeals represent 11.0% of all denials here, based on 1,042 reversals. The cross-contract rank is #14 of 37. This derived measure combines appeal filing and outcome, so it supplies scale context but does not identify clinical reasons, administrative errors, or coverage rules.
Ranks sixteen through twenty · Upper-middle request cohort
A substantial authorization workload
With 142,000 requests, this contract sits below the largest systems but above most smaller records. Its request-volume rank is #16 of 37. Volume shows the denominator behind approvals and denials; it is not a measure of plan quality, membership, benefit breadth, price, or future coverage decisions.
Ranks twenty-one through twenty-five · Lower-middle denial cohort
Below the center of the denial-rate ordering
At 6.7%, this contract sits in the lower-middle part of the observed distribution. The exact rank is #22 of 37. This is aggregate prior-authorization activity for the reporting window, not a probability that a particular service, drug, or beneficiary request will be denied.